Literature DB >> 23624752

Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low-dose methotrexate.

Ting-Shun Wang1, Tsen-Fang Tsai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 23624752     DOI： 10.2340/00015555-1619

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  5 in total

1.  Photoletter to the editor: Psoriatic erythroderma associated with bullous pemphigoid: clinical appearance and histopathology.

Authors:  Cristina Garrido Colmenero; Salvador Arias Santiago; Gonzalo Blasco Morente; Israel Pérez López; José Aneiros Fernández
Journal:  J Dermatol Case Rep       Date:  2015-03-31

Review 2.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

Review 3.  Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review.

Authors:  Chang-Yu Hsieh; Tsen-Fang Tsai
Journal:  Am J Clin Dermatol       Date:  2022-08-14       Impact factor: 6.233

Review 4.  Interaction of Psoriasis and Bullous Diseases.

Authors:  Teruki Dainichi; Kenji Kabashima
Journal:  Front Med (Lausanne)       Date:  2018-08-08

5.  Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review.

Authors:  Peng Cao; Wenjing Xu; Litao Zhang
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.